Navamedic ASA | Cash Flow

Fiscal year is January-December. All values NOK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,669.40
2,698.00
10,299.70
10,466.60
17,131.90
7,010.80
Depreciation, Depletion & Amortization
6,492.60
8,559.70
12,654.50
14,068.10
11,755.50
6,212.30
Other Funds
-
-
160.00
-
-
18,818
Funds from Operations
1,911.80
8,320.00
3,455.20
6,847.40
6,863.00
5,594.90
Changes in Working Capital
17,562.60
19,068.50
19,173.40
21,355.70
52,210.60
30,429.10
Net Operating Cash Flow
15,650.90
10,748.50
22,628.70
14,508.30
59,073.60
36,024
Capital Expenditures
2,249.70
887.50
782.80
1,675.90
7,064.20
Sale of Fixed Assets & Businesses
-
-
-
-
66.80
Purchase/Sale of Investments
-
-
23,541.00
-
-
Net Investing Cash Flow
2,249.70
887.50
24,323.80
1,675.90
6,997.40
Issuance/Reduction of Debt, Net
12,483.00
14,897.40
8,509.70
22,964.30
48,622.20
Net Financing Cash Flow
13,371.00
15,402.40
8,349.70
31,908.60
48,622.20
Net Change in Cash
1,379.00
3,932.00
6,120.50
14,503.70
3,445.00
Free Cash Flow
15,660.80
10,800.10
22,628.70
15,286.60
59,073.60
Change in Capital Stock
888.00
505.00
-
8,944.20
-
Exchange Rate Effect
3,150.60
165.70
534.00
1,220.70
9.00

About Navamedic ASA

View Profile
Address
Fornebuveien 42-44
Lysaker AK 1366
Norway
Employees -
Website http://www.navamedic.com
Updated 07/08/2019
Navamedic ASA is a medical technology company, which engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. It operates through Pharma and Healthcare Products, and Medtech segments. The company was founded in October 2002 and is headquartered in Lysaker, Norway.